Cassiopeia presents: CargoCoin

Cassiopeia Services, the boutique IR/PR agency leading the blockchain revolution is thrilled to announce CargoCoin as the fourth confirmed company presenting at our Symposium on Wednesday 21st November at the May Fair Hotel.

CargoCoin is revolutionising global trade and transport by implementing decentralised technologies into the supply chain. The company links the physical world of trade, transport and logistics with the blockchain by replacing paper documents with smart contracts and providing secure escrow payments throughout the process. Incorporating blockchain into the supply chain means stronger ethics, more sustainability and better consumer protection.

A supply chain encompasses many levels, from manufacturing to consumer use and multiple actors in between: producers, shippers, warehouses and governments to name only a few. The current globalised manufacturing system implies that these typically complex supply chains actually surpass geographical boundaries, sometimes intercontinentally. In the current model, this results in a lack of transparency. Consumers have limited knowledge and understanding of the manufacturing process, allowing flaws and discrepancies to go unnoticed by the public eye.

An open-sourced traceable supply-chain can help tackle problems like Payment Cycle, cybersecurity and Fraud Prevention by establishing a trust protocol, as records are inalterable and cannot be deleted. Furthermore, an integrated system is likely to reduce the time and costs involved in the process. It is estimated that costs of trade-related paperwork amount to about 15 to 20 percent of transport expenditure. With blockchain, key quality indicators can be recorded from IoT devices from each point of the product’s journey, lowering fees, which ultimately results in cost savings.

Joshua Alexander, investment advisor and cyber security auditor, will be presenting Cargo Coin this Wednesday at our symposium.

About Cassiopeia Investor Symposia

The Cassiopeia Symposia series are exclusive events for selected companies and investors to network in an informal and friendly setting. We facilitate connections and an ongoing dialogue between companies and market opinion leaders.

At the end of each presentation, investors will have the opportunity to ask the management team questions during a Q&A session, after which a fine selection of drinks and canapes will be offered to all our guests.

In addition to CargoCoin, we will introduce guests to Andalas Energy, an AIM-listed company which has been in the spotlight recently over its newly-acquired assets in the North Sea as well as its positioning in Indonesia; and Right of Reply, an innovative technology company with a flagship blockchain-powered platform for online reputation management, coming soon onto the LSE market. We will also hear from the developers of Neurotrader, a software application designed to maximise trading performance and generate consistent rates of returns to investors.

You can watch presentations from the previous symposia and exclusive interviews with CEOs on our YouTube channel here

REGISTER https://www.eventbrite.co.uk/e/cassiopeia-investor-symposium-tickets-47398735895

NeuroTrader: Harnessing biodata to optimise real-time trading performance

There are many factors one should consider before making decisions in the trading process. Whereas research about company performance, market outlook and stock trends are certainly important, there is also a psychological element that is very often overlooked by investors, which holds them back from gaining better returns from their trading activities.

Trading activity, often assumed to be based on logical and analytical behaviour in order to balance out the inherent risk and possible gains, is often strongly impacted by the trader’s state of mind. Stress, excitement and overstimulation are among the many variables which can lead to risky trading decisions and potential losses. The forces affecting trading decisions are indeed multifactorial but directly impact the outcomes.

Very often, financial losses can be attributed to poor decision making arising from fear, trepidation and anxiety, each of which show specific biological patterns. When investors get too emotionally involved with trading, they are more apt to take greater risks, which quite possibly lead to less favourable returns. Financial gains, on the other hand, tend to result from clarity and optimism, which have their own biological patterns, better known as “biomarkers”.

Emotions such as fear and greed are common in a trader’s daily life. Stocks and markets are, after all, fluid systems and bad news is bound to crop up. however, these emotions are misleading and as result, compromise trading performance. In order to ensure better results, traders should discipline themselves to override their instincts and move past the emotional response. This reflects on the figures; only 5% of traders make a profit at the end of the year.A reliable solution to prevent emotions from hindering optimal trading performance is a tool which provides insights into the trader’s neurosystem, informing smarter decisions. But is there such a solution without resorting to algorithms or robots?

NeuroTrader is a suite of software applications which can enhance traders’ decision-making effectiveness with wearable technology. Based on the concept of trading as a peak performance sport, NeuroTrader is creating the science of optimal decision making.

Real-time monitoring of the traders and their biodata provides an opportunity to mitigate risk, optimise performance and create stable and consistent rates of return as a function of the traders’ biological responses to price and market sentiment.

NeuroTrader is the system to help investors make better choices based on clinical analysis and objectivity. By analysing biodata collected via wearable technology, NeuroTrader can discern different human performance states and therefore inform trading decisions based upon the biological state of the trader, providing an advanced risk-management tool for every trade.

Neurotrader is initiating its pilot program in February next year, in which it will be monitoring 100 traders globally over a 6-month period. The NeuroTrader team, with 10 years of research and testing in the field, expect the platform to mitigate on average 20% of trading errors.

The industry has already taken the route of eliminating humans from trading and using machine learning to improve trading results, but the problem for financial institutions is that they have misunderstood the limitations of these technologies.

“There is a perfect middle ground where machines assist human performance; this is a paradigm-shift where machines serve people to achieve greater heights, not to make them redundant,” says Ken Medanic, the creator and founder of NeuroTrader.

NeuroTrader promises to be one of the first technologies to improve behavioural patterns in trading activity — suitable for both individuals and institutional investors. Hear more about this exciting tool in person. Don’t miss NeuroTrader’s presentation at Cassiopeia Investor Symposium! Register here

NeuroTrader: Harnessing biodata to optimise real-time trading performance

There are many factors one should consider before making decisions in the trading process. Whereas research about company performance, market outlook and stock trends are certainly important, there is also a psychological element that is very often overlooked by investors, which holds them back from gaining better returns from their trading activities.

Trading activity, often assumed to be based on logical and analytical behaviour in order to balance out the inherent risk and possible gains, is often strongly impacted by the trader’s state of mind. Stress, excitement and overstimulation are among the many variables which can lead to risky trading decisions and potential losses. The forces affecting trading decisions are indeed multifactorial but directly impact the outcomes.

Very often, financial losses can be attributed to poor decision making arising from fear, trepidation and anxiety, each of which show specific biological patterns. When investors get too emotionally involved with trading, they are more apt to take greater risks, which quite possibly lead to less favourable returns. Financial gains, on the other hand, tend to result from clarity and optimism, which have their own biological patterns, better known as “biomarkers”.

Emotions such as fear and greed are common in a trader’s daily life. Stocks and markets are, after all, fluid systems and bad news is bound to crop up. however, these emotions are misleading and as result, compromise trading performance. In order to ensure better results, traders should discipline themselves to override their instincts and move past the emotional response. This reflects on the figures; only 5% of traders make a profit at the end of the year.A reliable solution to prevent emotions from hindering optimal trading performance is a tool which provides insights into the trader’s neurosystem, informing smarter decisions. But is there such a solution without resorting to algorithms or robots?

NeuroTrader is a suite of software applications which can enhance traders’ decision-making effectiveness with wearable technology. Based on the concept of trading as a peak performance sport, NeuroTrader is creating the science of optimal decision making.

Real-time monitoring of the traders and their biodata provides an opportunity to mitigate risk, optimise performance and create stable and consistent rates of return as a function of the traders’ biological responses to price and market sentiment.

NeuroTrader is the system to help investors make better choices based on clinical analysis and objectivity. By analysing biodata collected via wearable technology, NeuroTrader can discern different human performance states and therefore inform trading decisions based upon the biological state of the trader, providing an advanced risk-management tool for every trade.

Neurotrader is initiating its pilot program in February next year, in which it will be monitoring 100 traders globally over a 6-month period. The NeuroTrader team, with 10 years of research and testing in the field, expect the platform to mitigate on average 20% of trading errors.

The industry has already taken the route of eliminating humans from trading and using machine learning to improve trading results, but the problem for financial institutions is that they have misunderstood the limitations of these technologies.

“There is a perfect middle ground where machines assist human performance; this is a paradigm-shift where machines serve people to achieve greater heights, not to make them redundant,” says Ken Medanic, the creator and founder of NeuroTrader.

NeuroTrader promises to be one of the first technologies to improve behavioural patterns in trading activity — suitable for both individuals and institutional investors. Hear more about this exciting tool in person. Don’t miss NeuroTrader’s presentation at Cassiopeia Investor Symposium! Register here

Cassiopeia Investor Symposium: Autumn 2018

Following on from the success of our previous symposia, the Cassiopeia team is back with our Autumn Symposium. We’ll be at the Mayfair Hotel in central London with exciting companies to watch out for. Save the date: 21st November 2018 from 6.30 pm.

Whether you’re a shareholder, investor or trader and regardless of your level of experience or strategy, the ethos of our symposia is to create an opportunity for investors to meet company directors and get actively involved in sourcing information. We facilitate connections and an ongoing dialogue between companies and market opinion leaders. Information is key to investment and trading.

The Cassiopeia Symposia series are exclusive events, only for selected companies and investors to network in an informal and friendly setting.

Investors are welcome to attend the presentations in what will be an relaxed atmosphere where they can meet company managers face to face and network with other existing shareholders or investors to discuss company strategy, plans, developments and value.

In this edition, we will introduce guests to Andalas Energy, an AIM-listed company which has been in the spotlight recently over its newly-acquired assets in the North Sea as well as their positioning in Indonesia; and Right of Reply, an innovative technology company with a flagship blockchain-powered platform for online reputation management, coming soon onto the LSE market.

We will also hear from the developers of Neurotrader, a software application designed to maximise trading performance and generate consistent rates of returns to investors.

At the end of each presentation, investors will have the opportunity to ask the management team questions during a Q&A session moderated by multi-awarded winning ADVFN International Financial Blogger Daniel Levi, aka the Infamous BrokermanDan.

Opinion leaders, market influencers and well-known City traders regularly attend our events.

Presenting companies:

Andalas Energy (LSE: ADL) is an AIM-listed Oil & Gas company with an international energy business focused on developing upstream assets, applying innovative solutions to generate revenue. Andalas is in partnership to develop a series of wellhead IPPs in Indonesia, and more recently acquired assets in the North Sea, while currently in discussion on new projects with a third party in Indonesia. Under new management, Andalas is operating with a fresh strategy and is committed to delivering value to its shareholders. Visit Andalas website for more information: http://www.andalasenergy.co.uk

Right of Reply (RoR) is an innovative Social Impact Technology company providing rapid, low-cost and legally sound solutions to individuals and enterprises to help manage their online reputations. With a fresh approach to a growing problem, RoR ensures everyone’s ability to counter unfair, inaccurate or incorrect content with timeliness and relevance. RoR offers platforms for regulated media, products for credit checking and scoring, as well as services for digital identity and social media. Visit Right of Reply website for more information: https://rightofreply.news

Neurotrader is a suite of software applications to enhance the decision-making effectiveness of the trader through the use of wearable technology. Based on the concept of trading as a peak performance sport, NeuroTrader is creating the science of optimal decision making for traders globally. Monitoring the trader and its biodata in real-time, it provides the opportunity to effectively mitigate risk and optimize performance and create stable, consistent rates of return as a function of their biological responses to price and market sentiment. Where performance is measured, monitored and managed. For more information on how to gain your trading competitive advantage, please visit NeuroTrader webiste: https://neurotrader.com

You can watch presentations from the previous symposia and exclusive interviews with CEOs on our YouTube channel here

A fine selection of drinks and canapes will be offered to all our guests. An evening you can’t miss!

Register here See you in November!